Boston Scientific Corp
Veridion Score
Composite trend over time
Why is BSX moving today?
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
BSX insider activity
Boston Scientific Corp
3 insiders bought in the last 90 days
Net selling: -$45.0M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-21 | 2026-05-20 | Pegus Cheryl | Insider | buy | $56.49 | 1,770 | 1,770 | $100K | SEC Form 4 |
| 2026-05-21 | 2026-05-20 | Habiger David C | Insider | buy | $55.92 | 2,250 | 13,878 | $126K | SEC Form 4 |
| 2026-05-21 | 2026-05-20 | LUDWIG EDWARD J | Insider | buy | $56.68 | 3,580 | 25,359 | $203K | SEC Form 4 |
| 2026-05-21 | 2026-05-19 | Habiger David C | Insider | buy | $56.95 | 2,200 | 11,628 | $125K | SEC Form 4 |
| 2026-05-04 | 2026-05-02 | O'Connor Padraig Andrew | Insider | sell | $56.50 | 872 | 7,024 | $49K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 58 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moBSX contract awards, year to date.
Public federal awards linked to this ticker.
YTTRIUM-90 (Y-90) THERASPHERE
THERASPHERE
THERASPHERE YTTRIUM-90 (Y-90) GLASS MICROSPHERES QTY: 14 EACH
THERASPHERE Y-90 GLASS MICROSPHERES
SUPPLY:ELUVIA US STENTS
BSX lobbying filings, year to date.
Registered lobbying filings matched to Boston Scientific Corp.